funder-graph

FundersVAAmerican Institute for Cancer Research › 2022

Grants paid by American Institute for Cancer Research, tax year 2022

EIN 52-1238026 · Arlington, VA · Form 990, Schedule I · NTEE H30Z

In tax year 2022, American Institute for Cancer Research (EIN 52-1238026) reported 6 grants paid totaling $1,155,000. Dataset version 2026.09.0, built 2026-09-03.

20182019202020212022202320242025

Every grant, 2022

Grants reported by American Institute for Cancer Research for tax year 2022
Tax yearRecipientMatchAmountTypePurposeSource filing
2022Children's Hospital Ca USA Los Angeles, CAA$247,500paidRESEARCH GRANT202331999349301178
2022The Regents of the University of Michigan Ann Arbor, MIA$247,500paidRESEARCH GRANT202331999349301178
2022The Regents of the University of California San Francisco San Francisco, CAA$165,000paidRESEARCH GRANT202331999349301178
2022The Children's Hospital of Philadelphia Philadelphia, PAA$165,000paidRESEARCH GRANT202331999349301178
2022Thomas Jefferson University Philadelphia, PAA$165,000paidRESEARCH GRANT202331999349301178
2022The Trustees of Columbia University in the City of New York New York, NYU$165,000paidRESEARCH GRANT202331999349301178

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.